Media

Senior Scientist
Full professor
Faculty of Medicine
Biochemistry, Microbiology and Immunology

Contact information:

Office: 613-737-7700 (70333)
Home: 613-521-0549
E-mail: jbell@ohri.ca

Preferred method of contact:

E-mail

Research information:

My lab is defining at the molecular level, the differences between normal and tumour tissues. Our plan is to develop novel cancer therapeutics that target tumour tissue but do not harm normal tissue. We are developing viruses that can infect and kill tumour cells but do not infect normal cells. These viruses are called Oncolytic Viruses

Area(s) of expertise:

(View other experts in this field)

• Biochemistry
• Biochemistry, microbiology and immunology
• Cancer
• Cellular and molecular medicine
• Diseases
• Genetics
• Genetics
• Medical research
• Microbiology
• Molecular biology
• Molecular biology
• Virology

Language preference:

English only

Part-time professor
Faculty of Medicine
Cellular and Molecular Medicine

Contact information:

Office: 613-737-8822
Home: 613-692-4672
E-mail: may.griffith@uOttawa.ca

Preferred method s of contact:

E-mail, Office Telephone

Research information:

Development of artificial tissues such as cornea for in-vitro safety and efficacy testing as alternatives to animal testing, and also for temporary and permanent implants. Development of in-vitro systems and essays for studying corneal wound healing and neuronal development.

Area(s) of expertise:

(View other experts in this field)

• Cellular and molecular medicine
• Ophthalmology
• Toxicology

Language preference:

English only

Associate professor
Faculty of Medicine
Cellular and Molecular Medicine

Contact information:

Office: 613-562-5800 (8156)
Office: 613-562-5800 (8397)
E-mail: jmrenaud@uOttawa.ca
Website

Preferred method s of contact:

E-mail, Office Telephone

Research information:

Mechanism of muscle fatigue. Mechanism of action of ATP-sensitive K+ channels in fatigue. Gene expression of K+. Channelopathies in skeletal muscle – Mechanism and treatment of hyperkalemic periodic paralysis

Area(s) of expertise:

(View other experts in this field)

• Cellular and molecular medicine
• Physiology

Language preference:

English and French

Canada Research Chair in Apoptotic Signaling
Associate professor
Faculty of Medicine
Cellular and Molecular Medicine

Contact information:

Office: 613-738-4180
E-mail: rob@arc.cheo.ca
Website

Research information:

Our lab is interested in understanding how human cells respond to extracellular cues to maintain and ensure their function and survival. One central focus is to study how the pancreatic beta cell converts feeding cues into signals leading to insulin production and secretion.

We use high-throughput functional screens to identify novel players involved in different cell-signaling pathways, including human pancreatic beta cell proliferation and those involved in the maintenance of mitochondria, critical subcellular organelles essential for cell function and survival. In addition to Type 1 and Type 2 diabetes, our work impacts upon cancer and neurodegeneration.

Area(s) of expertise:

(View other experts in this field)

• Cellular and molecular medicine
• Pediatrics

Language preference:

English only

Canada Research Chair in Hypertension, Senior Scientist / Ottawa Hospital Research Institute
Full professor
Faculty of Medicine
Medicine

Contact information:

Office: 613-562-5800 (8241)
Cell: 514-793-1472
Home: 613-744-5319
E-mail: rtouyz@uOttawa.ca

Preferred method of contact:

E-mail

Research information:

Dr Rhian Touyz, MBBCh, MSc(Med), PhD, is the Canada Research Chair in Hypertension at the Kidney Research Centre, Ottawa Hospital Research Institute (OHRI)/Univ of Ottawa. She is a Senior Scientist at the OHRI and professor of medicine in the Division of Nephrology. Dr Touyz received her BSc(Hons) (1980), MBBCh (1984), MSc (1986) and PhD (1992) from the University of the Witwatersrand, Johannesburg, South Africa. She completed a post-doctoral fellowship (1992-1996) at the Clinical Research Institute of Montreal, Quebec, Canada, under the supervision of Ernesto Schiffrin.

She has received numerous academic and research awards, including the Young Investigator Awards from the American Society of Hypertension, the Canadian Society of Hypertension and the Quebec Society of Hypertension as well as being a finalist for the Irving H Page Award, Atherosclerosis Thrombosis and Vascular Biology from the American Heart Association. Dr Touyz was  awarded the 2005 Dahl Lecture Award by the American Heart Association, the 2006 Grace A Goldsmith Award, American Society of Nutrition, the 2009 Vincenzo Panagia Distinguished Lecture Award, Institute of Cardiovascular Sciences Award and the 2010 Distinguished Service award from Hypertension Canada, in recognition of her contributions to hypertension research. She is the recipient of the prestigious Berne Lectureship Award of the American Physiological Society, Cardiovascular Section, 2012.

Dr Touyz co-chairs the Recommendations Task Force of the Canadian Hypertension Education Program (CHEP), responsible for the annual hypertension guidelines, she is the secretariat of the International Society of Hypertension and she is the past President of the Canadian Hypertension Society. She is the current Chair of the Council for High Blood Pressure Research, AHA. She is the Scientific Officer of the Cardiovascular committees at the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada (HSFC) and she is a member of the Microcirculation and Hypertension study section of the National Institute of Health, USA. Dr Touyz chairs the organization committee for establishment of the Vascular Medicine and Biology program, Dept of Medicine, Univ of Ottawa. She is Associate Editor of Clinical Science and the Journal of the American Society of Hypertension and she is on the editorial board of numerous specialty journals. She is the 2012 in-coming Editor-in-Chief of Clinical Science

Dr Touyz is funded by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC), Canadian Foundation for Innovation (CFI), Kidney Foundation of Canada and the Juvenile Diabetes Research Foundation (JDRF).  She has published over 260 original papers and more than 30 review articles. Her main focus of research relates to molecular, cellular and vascular mechanisms of hypertension. Her areas of study include clinical and experimental hypertension, hypertension in renal disease, signal transduction, oxidative stress, ion transport, vascular biology, adipose biology and insulin resistance and diabetes. Aa a clinician-scientist she has a particular interest in translational research.

Area(s) of expertise:

(View other experts in this field)

• Cellular and molecular medicine
• Diseases
• Medical research
• Molecular biology

Language preference:

English only

Dr.
Assistant professor
Faculty of Medicine
Cellular and Molecular Medicine

Contact information:

Office: 613-562-5800 (8068)
E-mail: ltrinkle@uOttawa.ca
Website

Preferred method of contact:

E-mail

Research information:

The typical mammalian cell expresses thousands of proteins, over a third of which are regulated by the reversible addition of a phosphate group. My laboratory studies the targeting and regulation of PP1, one of the key enzymes in the cell that removes these phosphate groups. By studying this phosphatase in living cells using cutting edge fluorescence microscopy techniques and novel methods for identifying protein complexes, we can define its roles in diverse intracellular signalling pathways and how it may be disrupted in disease states such as cancer and diabetes.

Area(s) of expertise:

(View other experts in this field)

• Biochemistry
• Cellular and molecular medicine
• Molecular biology

Language preference:

English only

Corinne Boyer Chair in Ovarian Cancer Research
Full professor
Faculty of Medicine
Cellular and Molecular Medicine

Contact information:

Office: 613-737-7700 (70330)
E-mail: bvanderhyden@ohri.ca
Website

Preferred method of contact:

E-mail

Research information:

Ovarian cancer, notably the cellular and molecular mechanisms that are important for the initiation and progression of ovarian tumours. Testing of novel therapeutics against ovarian cancer in women and in animal models of ovarian cancer. Transgenic (genetically modified) animals. Science education and outreach: Let's Talk Science program.

Area(s) of expertise:

(View other experts in this field)

• Animal physiology
• Cancer
• Cellular and molecular medicine
• Developmental biology
• Molecular biology
• Physiology
• Women’s health

Language preference:

English only